Lundbeck Philippines

Last updated: 13.02.2014

Address: 6/F Electra House Building, 115-117 Esteban Street, Legaspi Village, Makati City 1200 ,Philippines

Tel: +632 817-3021


Company description

Lundbeck is a global pharmaceutical company conducting research into, developing, manufacturing, marketing, selling and distributing pharmaceuticals for the treatment of disorders in the central nervous system (CNS), including depression, schizophrenia, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, epilepsy and insomnia.

Lundbeck employs 5,900 people worldwide, 2,100 of whom are based in Denmark. Employees are present in 56 countries, and products are registered in more than 100 countries. The production facilities are located in Italy and Denmark and the research centres in Denmark and the USA.

Lundbeck Philippines started its operations as a representative office in 2003.

Products and services

Lundbeck markets a number of different pharmaceuticals for the treatment of disorders of the central nervous system (CNS). The most recently launched compounds include: Cipralex/Lexapro (depression), Ebixa (Alzheimer’s disease), Azilect (Parkinson’s disease), Xenazine (chorea associated with Huntington’s disease), Serdolect (schizophrenia), Sabril (epilepsy) and Circadin (sleep disorders).



We use cookies to ensure that we give you the best experience on our site. For more info click here